**Top 5 Things You Need to Know About Mark Cuban’s Massive Pharmacy Pivot**
Top 5 Things You Need to Know About Mark Cuban’s Massive Pharmacy Pivot
- 1. He’s Slashing Prices to the Bone: In a direct assault on Big Pharma, Mark Cuban’s Cost Plus Drugs company just struck a deal to offer a blockbuster weight-loss and diabetes drug (Ozempic/Wegovy) for 95% less than retail prices. We’re talking a $1,000+ monthly invoice dropping to under $50.
- 2. The “Middleman Meltdown” is Real: Cuban isn’t just selling pills; he’s torching the entire pharmacy supply chain by manufacturing his own generic versions. This means he skips the Pharmacy Benefit Managers (PBMs) he calls “legalized price-fixers,” forcing traditional giants to finally blink on their sky-high markups.
- 3. He’s Taking on the Most Expensive Drug Class in History: GLP-1s (weight loss drugs) are currently America’s hottest—and most financially draining—medication category. By targeting this specific drug class, Cuban isn’t making a symbolic stand; he’s attacking the single biggest driver of rising healthcare costs for millions of patients.
- 4. It’s Going Viral on TikTok—But It’s Actually Legal: Unlike some of his Shark Tank deals, this isn’t hype. The FDA just gave the green light for his new facility. Real doctors can now prescribe, and the company is already processing thousands of orders from patients who previously went without due to cost.
- 5. His Real Endgame is a “Normal Person” IPO: Don’t call it a charity. Cuban said this model proves that lower prices can still be wildly profitable. He’s currently structuring the company so that everyday customers—not just Wall Street hedge funds—can buy shares first, potentially making this the most democratic (and disruptive) public